Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients (COMPETE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03049189 |
Recruitment Status :
Recruiting
First Posted : February 9, 2017
Last Update Posted : December 10, 2020
|
Sponsor:
ITM Solucin GmbH
Collaborators:
ABX CRO
PSI CRO AG
Information provided by (Responsible Party):
ITM Solucin GmbH
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | December 2023 |
Estimated Study Completion Date : | May 2024 |